Nicholas Conti

Dr. Nick Conti joined Quest Diagnostics corporate business development group in 2006 as a Vice President responsible for licensing and technology acquisitions as well as the development and management of strategic alliances.

Dr. Conti has been involved in the medical device, diagnostics and laboratory industry for over 23 years. He was Vice President for Business Development at Becton Dickinson where he led licensing efforts, strategic planning, and the new business incubator. He led development efforts and managed new business initiatives in point of care, healthcare IT, proteomics, molecular diagnostics, lab automation, and non-blood/non-invasive diagnostics. He was the Vice President of corporate development at Orchid Cellmark in 2005. Nick started his career and spent 10 years at Union Carbide first as a scientist engaged in catalysis research, then after receiving an MBA in finance from the Wharton School, he joined the corporate staff in licensing, M&A, and divestitures.

Dr. Conti has held academic appointments concurrent with his employment: Visiting Assistant Professor of Chemistry at Rutgers University and Adjunct Professor of Finance at Seton Hall University. He has served on the boards of public companies, private firms, and non-profit organizations in the fields of medical devices, diagnostic kits and services, laboratory services, and health care providers (hospital).